Fi

OTC products · Product label record

First Aid Antibiotic drug information

BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B, PRAMOXINE HCL
Walgreen Company · TOPICAL

Product NDC: 0363-0841

Join the community
CommunityExperiencesReviewsDrug database
Source label information, not individualized medical advice. This record applies to the product and labeler shown below. Compare the exact formulation, strength and country with your package and the current source label.
Generic nameBACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B, PRAMOXINE HCL
Labeler / manufacturerWalgreen Company
RouteTOPICAL
Drug classDrug class not supplied in source label
Product NDC0363-0841
Label effective date2026-09-03

Official product label reference

First Aid Antibiotic — Walgreen Company

This page contains 12 source sections for BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B, PRAMOXINE HCL, topical route. Label set b982091a-5aa0-4bbc-bb1d-08016f6d0a70, version 6.

Retrieved 2026-10-02 · openFDA dataset updated 2026-10-02 · Check the current DailyMed label

Label records can cover multiple strengths or package sizes. A label listing does not by itself establish FDA approval or current market availability. Check the source and application history for this specific product.

Uses described in the label

Uses first aid to help prevent infection and for temporary relief of pain or discomfort in minor: • cuts • scrapes • burns

Purpose

Purpose First aid antibiotic External analgesic
Dosage and administration — label text
Directions • adults and children 2 years of age and older: • clean the affected area • apply a small amount of this product (an amount equal to the surface area of the tip of a finger) on the area 1 to 3 times daily • may be covered with a sterile bandage • children under 2 years of age: ask a doctor
Warnings
Warnings For external use only. Do not use • if you are allergic to any of the ingredients • in the eyes • over large areas of the body Ask a doctor before use if you have • deep or puncture wounds • animal bites • serious burns Stop use and ask a doctor if • you need to use longer than 1 week • condition persists or gets worse • symptoms persist for more than 1 week, or clear up and occur again within a few days • rash or other allergic reaction develops Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away (1-800-222-1222).
Active ingredient
Active ingredients (in each gram) Bacitracin zinc 500 units Neomycin sulfate equivalent to 3.5 mg of neomycin base Polymyxin B 10,000 units as polymyxin B sulfate Pramoxine HCl 10 mg
Do not use
Do not use • if you are allergic to any of the ingredients • in the eyes • over large areas of the body
Ask a doctor before use
Ask a doctor before use if you have • deep or puncture wounds • animal bites • serious burns
When to stop use and seek help
Stop use and ask a doctor if • you need to use longer than 1 week • condition persists or gets worse • symptoms persist for more than 1 week, or clear up and occur again within a few days • rash or other allergic reaction develops
Child safety
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away (1-800-222-1222).
Storage and handling
Other information • store at 20-25 ° C (68-77 ° F)
Inactive ingredient
Inactive ingredients cocoa butter, cottonseed oil, olive oil, petrolatum, sodium pyruvate, tocopheryl acetate
Questions
Questions or comments? 1-800-719-9260

Official sources and product identifiers

Substances listed: BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, PRAMOXINE HYDROCHLORIDE

RxNorm identifiers: 1359350

Package NDC codes

0363-0841-58, 0363-0841-64

Further research and background

These are external searches for related information. Research, encyclopedia and news articles have not been imported into this product record.

Coverage and corrections

The text is extracted from a US structured product label. Tables are represented as text where supplied; formatting and illustrations may be lost. A missing section does not mean a risk is absent. This reference has not been independently reviewed by a clinician and is not a live safety-alert service.

Source retrieved 2026-10-02. Read the source policy.